AI assistant
Sending…
ASSEMBLY BIOSCIENCES, INC. — Director's Dealing 2022
May 27, 2022
33081_dirs_2022-05-27_d9fea2df-8fed-42c1-9594-fb4f6d0e0bc5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2022-05-25
Reporting Person: Johnson-Pratt Lisa (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-05-25 | Stock Option (right to buy) | $1.69 | A | 20000 | Acquired | 2032-05-25 | Common Stock (20000) | Direct |
Footnotes
F1: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 25, 2023 and (2) the date of the Issuer's 2023 annual meeting of stockholders.
More from ASSEMBLY BIOSCIENCES, INC.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 19
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2025
Dec 8
Regulatory Filings
2025
Nov 21